Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

Journal of Antimicrobial Chemotherapy

Volumn 72, Issue 1, 2017, Pages 166-171

  Jean, Shio Shin ^a,b   Hsueh, Po Ren ^c   Korman, Tony ^d   Ellem, Justin ^e   George, Narelle ^f   Coombs, Geoffrey ^g   Ling, Thomas ^h   Tsang, Owen ⁱ   Balaji, V ^j   Mikamo, Hiroshige ^k   Kusachi, Shinya ^l   Mizutani, Tetsu ^m   Kim, Min Ja ⁿ   Bae, In Gyu ^o   Umur, Nurulhuda Binti ^p   Rajasekaram, Datin Ganeswrie ^q   Taylor, Susan ^r   Roberts, Sally ^s   van der Werff, Koen ^t   Drinkovic, Dragana ^u   Lagamayo, Evelina ^v   Mendoza, Myrna ^w   Tan, Thean Yen ^x   Krishnan, Prabha ^y   Wang, Ellie ^z   Lu, Po Liang ^aa   Liu, Chun Eng ^ab   Chuang, Kenneth Yin Ching ^ac   Yu, Kwok Woon ^ad   Chen, Yao Shen ^ae   Lu, Min Chi ^af   Panthuwong, Siripen ^ag   Kiratisin, Pattarachai ^ah   Phoung, Nguyen Tran My ^ai   Phuong, Doan Mai ^aj   Van, Nguyen Thi ^ak   Nga, Tran Thi Thanh ^al   more..

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d MONASH MEDICAL CENTRE   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

^f ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^g ROYAL PERTH HOSPITAL   (Australia)

^h CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

ⁱ PRINCESS MARGARET HOSPITAL   (Hong Kong)

^j CHRISTIAN MEDICAL COLLEGE   (India)

^k AICHI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^l TOHO UNIVERSITY   (Japan)

^m OSAKA POLICE HOSPITAL   (Japan)

ⁿ College of Medicine   (South Korea)

^o Gyeongsang National University   (South Korea)

^p HOSPITAL KUALA LUMPUR   (Malaysia)

^q Hospital Sul tanah Aminah Johin Bahru   (Malaysia)

^r MIDDLEMORE HOSPITAL   (New Zealand)

^s AUCKLAND CITY HOSPITAL   (New Zealand)

^t WELLINGTON HOSPITAL   (New Zealand)

^u NORTH SHORE HOSPITAL   (New Zealand)

^v ST LUKE S MEDICAL CENTER   (Philippines)

^w PHILIPPINE GENERAL HOSPITAL   (Philippines)

^x CHANGI GENERAL HOSPITAL   (Singapore)

^y TAN TOCK SENG HOSPITAL   (Singapore)

^z NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^aa KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^ab CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^ac CHI MEI MEDICAL CENTER   (Taiwan)

^ad TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^ae KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^af CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^ag Songklanakarin Hospital   (Thailand)

^ah MAHIDOL UNIVERSITY   (Thailand)

^ai An Binh Hospital   (Viet Nam)

^aj Service de Rhumatologie   (Viet Nam)

^ak VIET DUC HOSPITAL   (Viet Nam)

^al CHO RAY HOSPITAL   (Viet Nam)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAMASE; BETA LACTAMASE AMPC; CARBAPENEMASE; CEFOXITIN; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; BETA LACTAM;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; BACTERIUM DETECTION; BACTERIUM ISOLATE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENZYME LOCALIZATION; ESCHERICHIA COLI; GEOGRAPHIC DISTRIBUTION; HUMAN; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PACIFIC ISLANDS; PHILIPPINES; URINARY TRACT INFECTION; VIET NAM; CLASSIFICATION; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; EPIDEMIOLOGICAL MONITORING; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; ASIA; BETA-LACTAMASES; BETA-LACTAMS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; EPIDEMIOLOGICAL MONITORING; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTIPLEX POLYMERASE CHAIN REACTION; PACIFIC ISLANDS; URINARY TRACT INFECTIONS;

EID: 85014571133     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw398     Document Type: Article

References (20)

1. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8: 159-66.
2. Jean SS, Lee WS, Lam C et al. Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options. Future Microbiol 2015; 10: 407-25.
3. Jacoby GA. AmpC β-lactamases. Clin Microbiol Rev 2009; 22: 161-82.
4. Hyle EP, Lipworth AD, Zaoutis TE et al. Risk factors for increasing multidrug resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species. Clin Infect Dis 2005; 40: 1317-24.
5. Jean SS, Hsueh PR. High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents 2011; 37: 291-5.
6. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistancemechanismin India, Pakistan, and the UK: amolecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
7. Sheng WH, Badal RE, Hsueh PR; SMART Program. Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 2013; 57: 2981-8.
8. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fifth Informational Supplement M100-S25. CLSI, Wayne, PA, USA, 2015.
9. Lob SH, Kazmierczak KM, Badal RE et al. Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009. to 2013. Antimicrob Agents Chemother 2015; 59: 3606-10.
10. D'Andrea MM, Arena F, Pallecchi L et al. CTX-M-type β-lactamases: a successful story of antibiotic resistance. Int J Med Microbiol 2013; 303: 305-17.
11. Kuroda H, Yano H, Hirakata Y et al. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Japan: emergence of CTX-M-15-producing E. coli ST131. Diagn Microbiol Infect Dis 2012; 74: 201-3.
12. Biedenbach DJ, Bouchillon SK, Hoban DJ et al. Antimicrobial susceptibility and extended-spectrum β-lactamase rates in aerobic Gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011). Diagn Microbiol Infect Dis 2014; 79: 463-7.
13. Li Y, Li Q, Du Y et al. Prevalence of plasmid-mediated AmpC β-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-type AmpC β-lactamase resistance in China. J Clin Microbiol 2008; 46: 1317-21.
14. Oteo J, Cercenado E, Cuevas O et al. AmpC β-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131. Diagn Microbiol Infect Dis 2010; 67: 270-6.
15. Yoo JS, Byeon J, Yang J et al. High prevalence of extended-spectrum β-lactamases and plasmid-mediated AmpC β-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea. Diagn Microbiol Infect Dis 2010; 67: 261-5.
16. Hudson CM, Bent ZW, Meagher RJ et al. Resistance determinants and mobile genetic elements of an NDM-1-encoding Klebsiella pneumoniae strain. PLoS ONE 2014; 9: e99209.
17. Carrër A, Poirel L, Yilmaz M et al. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother 2010; 54: 1369-73.
18. Hoang TH, Wertheim H, Minh NB et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains containing New Delhi metallo-β-lactamase isolated from two patients in Vietnam. J Clin Microbiol 2013; 51: 373-4.
19. NDM-1-positive Klebsiella pneumoniae from environment, Vietnam. Emerg Infect Dis 2012; 18: 1383-5.
20. Rodríguez-Baño J, Picón E, Gijón P et al. Community-onset bacteremia due to extended-spectrum-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 2010; 50: 40-8.